With four FDA inspected sites in the USA, China, Ireland, and Portugal, and development laboratories in Lisbon and New Jersey the company focuses on the most demanding customers in the most regulated markets. The company also offers branded pharmaceutical customers services for the development and compliant manufacture of innovative new drugs, and is able to support highly potent compounds. In the inhalation area Hovione is the only independent company offering a complete range of services.
Since joining Britest in 2006 Hovione has regularly invested in their staff skills through Britest practitioner and facilitation skills in locations from Portugal, to the United States and Macau, reaping the benefits in numerous successful projects to enhance efficiency in both generic and branded products, and in technology transfer. Hovione have also taken advantage of the Britest approach's capacity to accommodate facilitation of cross supply chain discussions.
In an internal 2014 survey Hovione estimated that Britest tools were being used in 85% of development stage and 64% of commercial stage projects. Hovione regards Britest as a valuable, business driven organisational development tool, fostering entrepreneurial behaviour, and better knowledge management.